Role of microRNAs in inflammation-associated liver cancer

来源 :Cancer Biology & Medicine | 被引量 : 0次 | 上传用户:weiwei05516
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Liver cancer, primarily hepatocellular carcinoma(HCC), is a major cause of cancer-related death worldwide. HCC is a suitable model of inflammation-induced cancer because more than 90% of HCC cases are caused by liver damage and chronic inflammation. Several inflammatory response pathways, such as NF-κB and JAK/STAT3 signaling pathways, play roles in the crosstalk between inflammation and HCC. MicroRNAs(miRNAs) are evolutionarily conserved, short endogenous, non-coding single-stranded RNAs that are involved in various biological and pathological processes by regulating gene expression and protein translation. Evidence showed that miRNAs play a pivotal role in hepatitis virus infection and serve as promoters or inhibitors of inflammatory response. Aberrant miRNA was observed during liver inflammation and HCC. Many dysregulated miRNAs modulate the initiation and progression of inflammation-induced HCC. This review summarizes the role and functions of miRNAs in inflammation-associated HCC, as well as the designed therapeutics targeting miRNAs to treat liver inflammation and HCC. HCC is a suitable model of inflammation-induced cancer because more than 90% of HCC cases have caused by liver damage and chronic inflammation. Several inflammatory response pathways, such as NF-κB and JAK / STAT3 signaling pathways, play roles in the crosstalk between inflammation and HCC. MicroRNAs (miRNAs) are evolutionarily conserved, short endogenous, non-coding single-stranded RNAs that are involved in various biological and pathological processes by regulating gene expression and protein translation. Evidence showed that miRNAs play a pivotal role in hepatitis virus infection and serve as promoters or inhibitors of inflammatory response. Aberrant miRNA was observed during liver inflammation and HCC. Many dysregulated miRNAs modulate the initiation and progression of inflammation-induced HCC. This review summarizes the role and functions of miRNAs in inflammation-associated HCC , as well as the designed therapeutics targeting miRNAs to treat liver inflammation and HCC.
其他文献
期刊
期刊
期刊
本月全球药品研发进展取得成效的药物有30个,较上月减少1个.与上月相比,进入注册阶段的药品数量减少4个,注册前阶段的数量持平.而Ⅲ期临床阶段的药品数量则增加3个,保持了继1
Objective: Implantable port thrombosis(IPT) in cancer patients is a relatively rare but severe complication. Several factors are reportedly associated with the
目的探讨运动与血钙离子的相关性,为临床诊治提供依据。方法选用两组健康人:年龄40~60岁,内科检查无器质性病变,分别为常规心电图正常组和ST-T异常改变组,应用标准Bruce方案
期刊
期刊